Shire weighs spin-off for ADHD drugs division

London-listed pharma group lifts sales and trumpets cost savings from Baxalta deal
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: ADHD | Pharmaceuticals